An implantable visual prosthetic for end-stage macular degeneration

Expert Review of Ophthalmology

Volumn 6, Issue 2, 2011, Pages 141-145

  Bansal, Alok S ^a   Baker, Paul ^a   Haller, Julia A ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

age related macular degeneration; geographic atrophy; Implantable Miniature Telescope; visual prosthetic; visual rehabilitation

Indexed keywords

CORTICOSTEROID;

ARTICLE; CATARACT; CATARACT EXTRACTION; CENTRAL SCOTOMA; CONTACT LENS; DEVICE APPROVAL; DEVICE SAFETY; DISEASE SEVERITY; END STAGE RETINA MACULA AGE RELATED DEGENERATION; EYE INFLAMMATION; FOOD AND DRUG ADMINISTRATION; HUMAN; IMPLANTABLE VISUAL PROSTHESIS; LENS; LENS CAPSULE; MEDICAL TECHNOLOGY; PERIPHERAL VISION; POSTMARKETING SURVEILLANCE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; REHABILITATION CARE; RETINA MACULA AGE RELATED DEGENERATION; SPECTACLES; TREATMENT INDICATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL PROSTHESIS;

EID: 79955063984     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.11.18     Document Type: Article

References (17)

1. Friedman DS, O'Colmain BJ, Munoz B; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 123, 564-572 (2004). (Pubitemid 38456293)
2. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119(10), 1439-1452 (2001).
3. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin - TAP report 2. Arch. Ophthalmol. 119, 198-207 (2001).
4. Rosenfeld PJ, Brown DM, Heier JS; MARINA study group. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355(14), 1419-1431 (2006). (Pubitemid 44511557)
5. Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr. Opin. Ophthalmol. 15, 181-183 (2004). (Pubitemid 38638861)
6. Brown MM, Brown GC, Sharma S et al. The burden of age-related macular degeneration: a value-based analysis. Curr. Opin. Ophthalmol. 17, 257-266 (2006). (Pubitemid 44309749)
7. Lipshitz I, Sheah AD, Loewnstein A. The implantable miniaturized telescope for patients with age-related macular degeneration: design and surgical technique. Operat. Techn. Cataract Refract Surg. 3, 53-58 (2000).
8. Peli E. The optical functional advantages of an intraocular low-vision telescope. Optom. Vis. Sci. 79, 225-233 (2002). (Pubitemid 34311065)
9. Colby KA, Chang DF, Stulting RD et al. Surgical placement of an optical prosthetic device for end-stage macular degeneration: the Implantable Miniature Telescope. Arch. Ophthalmol. 125, 1118-1121 (2007). (Pubitemid 47258046)
10. Hudson HL, Lane SS, Heier JS et al. Implantable Miniature Telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: 1-year results. Ophthalmology 113, 1987-2001 (2006). (Pubitemid 44635735)
11. Primo SA. Implantable Miniature Telescope: lessons learned. Optometry 81, 86-93 (2010).
12. Lane SS, Kuppermann BD, Fine IH et al. A prospective multicenter trial to evaluate the safety and effectiveness of the Implantable Miniature Telescope. Am. J. Ophthalmol. 137, 993-1001 (2004). (Pubitemid 38759346)
13. Hudson HL, Stulting RD, Heier JS et al.; IMT-002 study group. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am. J. Ophthalmol. 146, 664-673 (2008).
14. Garfinkel RA, Berinstein DM, Frantz R. Treatment of choroidal neovascularization through the Implantable Miniature Telescope. Am. J. Ophthalmol. 141(4), 766-767 (2006).
15. Orzalesi N, Pierrottet CO, Zenoni S et al. The IOL-Vip System - a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology 114(5), 860-865 (2007).
16. Ahuja AK, Dorn JD, Caspi A et al.; Argus II study group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br. J. Ophthalmol. 95(4), 539-543 (2010).
17. Zrenner E, Bartz-Schmidt KU, Benav H et al. Subretinal electronic chip allows blind patients to read letters and combine them into words. Proc. Biol. Sci. DOI: 10.1098/rspb.2010.1747 (2010) (Epub ahead of print).